NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

The difference between Amarin and NWBO is that Amarin knew they would have actual valid topline data to present, based on a trial they designed and followed as planned. It's hard to present a timeline when the only valid topline data you have shows the vaccine failing to demonstrate efficacy for PFS as the primary endpoint. They've got nothing else that is valid.